- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
COHR buys four equipment service firms
The corporate shopping spree at COHR continues. The fast-growingChatsworth, CA, independent service organization added four morecompanies to its portfolio last month, bringing to 19 the numberof equipment sales and service firms COHR has purchased over
The corporate shopping spree at COHR continues. The fast-growingChatsworth, CA, independent service organization added four morecompanies to its portfolio last month, bringing to 19 the numberof equipment sales and service firms COHR has purchased over thepast three years.
The largest of the four acquired companies is the MediQuip Sterilizerdivision of Stryker, which focuses on sterilizer sales, repair,and maintenance and had sales of $9.4 million in 1996. Next inline is RadServ of Charleston, WV, which sells and services Siemensradiology and radiation oncology equipment, with annual revenuesof $2.5 million. The RadServ acquisition will allow COHR to decreaseits subcontracted maintenance services in radiology to its COHRMasterPlan customers.
Two smaller firms that COHR acquired included the Fresno officeof Biomedical Engineering Center of Sutter/CHS, a small laboratoryand biomedical service group with annual sales of $500,000. COHRalso purchased Triad Medical Services of Arlington, WA, whichsells and services imaging equipment and posted revenues of $500,000last year.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
